Difference between revisions of "Case Studies/GlaxoSmithKline"
(Created page with "{{Case Study |Description=GlaxoSmithKline (a UK pharmaceutical company) has waived all copyright restrictions to its malaria data set, which includes more than 13,000 compounds k...") |
(No difference)
|
Revision as of 20:33, 20 August 2010
GlaxoSmithKline (a UK pharmaceutical company) has waived all copyright restrictions to its malaria data set, which includes more than 13,000 compounds known to be active against malaria.
—
Overview
GlaxoSmithKline is a UK pharmaceutical company that has released a data set of 13,500 known compounds known to be active against malaria. The data set is called Tres Cantos Antimalarial (TCAMS), and is available from the ChEMBL-NTD database, "a repository for Open Access primary screening and medicinal chemistry data directed at neglected diseases - endemic tropical diseases of the developing regions of the Africa, Asia, and the Americas."
License Usage
GlaxoSmithKline has waived all copyright restrictions to its malaria data set under the CC0 public domain waiver.
